Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
INMD InMode	$14.35 +0.5%	$14.27	$13.14 ▼ $19.85	$907.05M	1.93	1.15 million shs	948,568 shs
IRMD iRadimed	$70.38 +0.3%	$61.30	$43.17 ▼ $73.47	$895.23M	0.94	56,223 shs	51,125 shs
OM Outset Medical	$13.29 +3.1%	$17.97	$5.85 ▼ $25.35	$236.16M	2.14	354,499 shs	194,871 shs
TNDM Tandem Diabetes Care	$10.82 +1.5%	$16.59	$9.98 ▼ $47.60	$731.11M	1.46	2.67 million shs	2.13 million shs

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
INMD InMode	0.00%	+1.70%	+3.24%	-1.24%	-10.31%
IRMD iRadimed	0.00%	+0.64%	+24.15%	+29.83%	+57.73%
OM Outset Medical	0.00%	+3.83%	-23.71%	-32.12%	+33.43%
TNDM Tandem Diabetes Care	0.00%	-3.65%	-26.74%	-52.40%	-75.79%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
INMD InMode	2.8261 of 5 stars	3.1	2.0	0.0	0.0	2.5	1.7	1.9
IRMD iRadimed	4.5669 of 5 stars	1.5	4.0	1.7	4.4	3.3	4.2	1.9
OM Outset Medical	1.3483 of 5 stars	3.5	2.0	0.0	0.0	1.3	0.0	0.0
TNDM Tandem Diabetes Care	4.5688 of 5 stars	4.1	3.0	0.0	4.9	2.7	1.7	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
INMD InMode	2.13	Hold	$18.04	25.73% Upside
IRMD iRadimed	3.00	Buy	$72.00	2.30% Upside
OM Outset Medical	3.00	Buy	$24.67	85.60% Upside
TNDM Tandem Diabetes Care	2.20	Hold	$22.67	109.49% Upside

Current Analyst Ratings Breakdown

Latest OM, INMD, IRMD, and TNDM Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/11/2025	TNDM Tandem Diabetes Care	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold	$75.00 ➝ $12.00
8/8/2025	TNDM Tandem Diabetes Care	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$53.00 ➝ $51.00
8/7/2025	TNDM Tandem Diabetes Care	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$59.00 ➝ $24.00
8/7/2025	TNDM Tandem Diabetes Care	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Neutral	$30.00 ➝ $14.00
8/7/2025	OM Outset Medical	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Sector Perform ➝ Sector Perform	$21.00 ➝ $22.00
8/7/2025	TNDM Tandem Diabetes Care	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$20.00 ➝ $17.00
8/7/2025	TNDM Tandem Diabetes Care	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$20.00 ➝ $13.00
8/7/2025	TNDM Tandem Diabetes Care	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$45.00 ➝ $25.00
7/30/2025	INMD InMode	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold
7/30/2025	INMD InMode	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$24.00 ➝ $21.00
7/14/2025	OM Outset Medical	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$37.00

(Data available from 8/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
INMD InMode	$401.56M	2.26	$1.82 per share	7.87	$10.12 per share	1.42
IRMD iRadimed	$73.24M	12.22	$1.58 per share	44.48	$6.85 per share	10.27
OM Outset Medical	$113.69M	2.08	N/A	N/A	$7.49 per share	1.77
TNDM Tandem Diabetes Care	$940.20M	0.78	N/A	N/A	$4.01 per share	2.70

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
INMD InMode	$181.27M	$2.47	5.81	7.88	N/A	44.50%	18.38%	16.35%	10/29/2025 (Estimated)
IRMD iRadimed	$19.23M	$1.62	43.44	35.19	N/A	26.61%	23.30%	20.62%	10/30/2025 (Estimated)
OM Outset Medical	-$127.98M	-$20.29	N/A	∞	N/A	-82.06%	-97.17%	-32.84%	11/5/2025 (Estimated)
TNDM Tandem Diabetes Care	-$96.03M	-$3.09	N/A	N/A	N/A	-20.51%	-65.40%	-13.87%	11/5/2025 (Estimated)

Latest OM, INMD, IRMD, and TNDM Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/6/2025	Q2 2025	TNDM Tandem Diabetes Care	-$0.40	-$0.48	-$0.08	-$0.78	$238.39 million	$240.68 million
7/30/2025	Q2 2025	INMD InMode	$0.50	$0.47	-$0.03	$0.42	$98.45 million	$95.60 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
INMD InMode	N/A	N/A	N/A	N/A	N/A
IRMD iRadimed	$0.68	0.97%	N/A	41.98%	1 Years
OM Outset Medical	N/A	N/A	N/A	N/A	N/A
TNDM Tandem Diabetes Care	N/A	N/A	N/A	N/A	N/A

Latest OM, INMD, IRMD, and TNDM Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/31/2025	IRMD iRadimed	quarterly	$0.17	1.13%	8/18/2025	8/18/2025	8/28/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
INMD InMode	N/A	9.60	8.58
IRMD iRadimed	N/A	8.78	7.51
OM Outset Medical	0.63	7.47	6.05
TNDM Tandem Diabetes Care	2.32	2.44	1.88

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
INMD InMode	68.04%
IRMD iRadimed	92.34%
OM Outset Medical	N/A
TNDM Tandem Diabetes Care	N/A

Insider Ownership

Company	Insider Ownership
INMD InMode	6.92%
IRMD iRadimed	36.80%
OM Outset Medical	2.40%
TNDM Tandem Diabetes Care	1.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
INMD InMode	480	63.21 million	58.84 million	Optionable
IRMD iRadimed	110	12.72 million	8.04 million	Optionable
OM Outset Medical	520	17.77 million	17.34 million	Not Optionable
TNDM Tandem Diabetes Care	2,650	67.57 million	66.29 million	Optionable

OM, INMD, IRMD, and TNDM Headlines

Recent News About These Companies

Sector Gamma AS Acquires New Shares in Tandem Diabetes Care, Inc. (NASDAQ:TNDM)

August 17 at 6:54 AM | marketbeat.com

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Given Consensus Rating of "Hold" by Brokerages

August 15 at 2:38 AM | marketbeat.com

Tandem Diabetes Care, Inc. (TNDM) Investors Who Lost Money - Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

August 14, 2025 | tmcnet.com

Securities Fraud Investigation Into Tandem Diabetes Care, Inc. ...

August 14, 2025 | gurufocus.com

Securities Fraud Investigation Into Tandem Diabetes Care, Inc. (TNDM) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

August 14, 2025 | businesswire.com

Tandem Diabetes Care, Inc. (TNDM) Investors Who Lost Money -- Contact Law Offices of Howard G. ...

August 14, 2025 | gurufocus.com

Tandem Diabetes Care, Inc. (TNDM) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

August 14, 2025 | businesswire.com

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives Consensus Rating of "Hold" from Analysts

August 14, 2025 | americanbankingnews.com

Tandem Diabetes Care (NASDAQ:TNDM) Cut to "Hold" at Lake Street Capital

August 14, 2025 | americanbankingnews.com

Securities Fraud Investigation Into Tandem Diabetes Care, Inc. (TNDM) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

August 13, 2025 | businesswire.com

Tandem Diabetes Care (NASDAQ:TNDM) Shares Gap Up Following Insider Buying Activity

August 13, 2025 | marketbeat.com

5 Insightful Analyst Questions From Tandem Diabetes’s Q2 Earnings Call

August 13, 2025 | finance.yahoo.com

Tandem Diabetes Care: Strategic Growth Potential and Market Expansion Drive Buy Rating

August 13, 2025 | tipranks.com

Tandem Diabetes Care Gains FDA Clearance for SteadiSet

August 13, 2025 | theglobeandmail.com

Tandem Diabetes Care (TNDM) was downgraded to a Hold Rating at Piper Sandler

August 13, 2025 | theglobeandmail.com

Tandem Diabetes Care (NASDAQ:TNDM) Shares Gap Up After Insider Buying Activity

August 13, 2025 | americanbankingnews.com

Citigroup Upgrades Tandem Diabetes Care (TNDM)

August 12, 2025 | msn.com

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) CEO Acquires $102,300.00 in Stock

August 12, 2025 | marketbeat.com

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) CFO Acquires $149,410.80 in Stock

August 12, 2025 | marketbeat.com

Tandem Diabetes, iRhythm, agilon health, Fortrea, and 10x Genomics Shares Skyrocket and Plummet, What You Need To Know

August 12, 2025 | msn.com

Tandem Diabetes upgraded at Citi on risk-reward setup

August 12, 2025 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

OM, INMD, IRMD, and TNDM Company Descriptions

InMode NASDAQ:INMD

$14.35 +0.07 (+0.49%)

Closing price 08/15/2025 04:00 PM Eastern

Extended Trading

$14.35 0.00 (0.00%)

As of 08/15/2025 07:53 PM Eastern

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

iRadimed NASDAQ:IRMD

$70.38 +0.23 (+0.33%)

Closing price 08/15/2025 04:00 PM Eastern

Extended Trading

$70.44 +0.06 (+0.08%)

As of 08/15/2025 04:10 PM Eastern

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

Outset Medical NASDAQ:OM

$13.29 +0.40 (+3.10%)

Closing price 08/15/2025 04:00 PM Eastern

Extended Trading

$13.20 -0.08 (-0.64%)

As of 08/15/2025 04:57 PM Eastern

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Tandem Diabetes Care NASDAQ:TNDM

$10.82 +0.16 (+1.50%)

Closing price 08/15/2025 04:00 PM Eastern

Extended Trading

$10.93 +0.11 (+1.02%)

As of 08/15/2025 07:58 PM Eastern

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time